Panretin is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Alitretinoin.
| Product ID | 62856-601_50ab2ed7-651c-4952-91d6-5011709ae429 |
| NDC | 62856-601 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Panretin |
| Generic Name | Alitretinoin |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2009-02-03 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020886 |
| Labeler Name | Eisai Inc. |
| Substance Name | ALITRETINOIN |
| Active Ingredient Strength | 60 mg/60g |
| Pharm Classes | Retinoid [EPC],Retinoids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2009-02-03 |
| Marketing End Date | 2021-10-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020886 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2009-02-03 |
| Marketing End Date | 2021-10-31 |
| Ingredient | Strength |
|---|---|
| ALITRETINOIN | 60 mg/60g |
| SPL SET ID: | 13c5de6d-d266-4d83-99c4-072ef104e7ff |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59212-601 | PANRETIN | alitretinoin |
| 62856-601 | Panretin | Alitretinoin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PANRETIN 74700355 2149627 Live/Registered |
EISAI INC. 1995-07-12 |